FDA Hoping To Shift Some ‘Cures’ Initiatives Toward User Fee Negotiations
This article was originally published in The Pink Sheet Daily
Executive Summary
As Rep. Upton signals an impending deal, Ostroff The Caretaker strikes a much more conciliatory tone than his predecessor as commissioner, Margaret Hamburg, did.